Muso E - Search Results

1

Impaired HVJ-stimulated Interferon producing capacity in MPO-ANCA-associated vasculitis with rapidly progressive glomerulonephritis lead to susceptibility to infection.

Uno K, Muso E, Ito-Ihara T, Endo T, Yasuda Y, Yagi K, Suzuki K. Uno K, et al. Among authors: muso e. Cytokine. 2020 Dec;136:155221. doi: 10.1016/j.cyto.2020.155221. Epub 2020 Aug 19. Cytokine. 2020. PMID: 32828064

2

Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.

Muso E, Ito-Ihara T, Ono T, Imai E, Yamagata K, Akamatsu A, Suzuki K. Muso E, et al. Jpn J Infect Dis. 2004 Oct;57(5):S17-8. Jpn J Infect Dis. 2004. PMID: 15507757 Clinical Trial.

3

Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis.

Ito-Ihara T, Ono T, Nogaki F, Suyama K, Tanaka M, Yonemoto S, Fukatsu A, Kita T, Suzuki K, Muso E. Ito-Ihara T, et al. Among authors: muso e. Nephron Clin Pract. 2006;102(1):c35-42. doi: 10.1159/000088313. Epub 2005 Sep 19. Nephron Clin Pract. 2006. PMID: 16174989

4

A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.

Ito-Ihara T, Muso E, Kobayashi S, Uno K, Tamura N, Yamanishi Y, Fukatsu A, Watts RA, Scott DG, Jayne DR, Suzuki K, Hashimoto H. Ito-Ihara T, et al. Among authors: muso e. Clin Exp Rheumatol. 2008 Nov-Dec;26(6):1027-33. Clin Exp Rheumatol. 2008. PMID: 19210866

5

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.

Smith RM, Jones RB, Specks U, Bond S, Nodale M, Aljayyousi R, Andrews J, Bruchfeld A, Camilleri B, Carette S, Cheung CK, Derebail V, Doulton T, Forbess L, Fujimoto S, Furuta S, Gewurz-Singer O, Harper L, Ito-Ihara T, Khalidi N, Klocke R, Koening C, Komagata Y, Langford C, Lanyon P, Luqmani RA, Makino H, McAlear CA, Monach P, Moreland LW, Mynard K, Nachman P, Pagnoux C, Pearce F, Peh CA, Pusey C, Ranganathan D, Rhee RL, Spiera R, Sreih AG, Tesar V, Walters G, Weisman MH, Wroe C, Merkel PA, Jayne D; RITAZAREM coinvestigators; RITAZAREM co-investigators. Smith RM, et al. Ann Rheum Dis. 2020 Sep;79(9):1243-1249. doi: 10.1136/annrheumdis-2019-216863. Epub 2020 Jun 24. Ann Rheum Dis. 2020. PMID: 32581088 Free PMC article.

6

Trafficking of QD-conjugated MPO-ANCA in murine systemic vasculitis and glomerulonephritis model mice.

Hoshino A, Nagao T, Ito-Ihara T, Ishida-Okawara A, Uno K, Muso E, Nagi-Miura N, Ohno N, Tokunaka K, Naoe S, Hashimoto H, Yasuhara M, Yamamoto K, Suzuki K. Hoshino A, et al. Among authors: muso e. Microbiol Immunol. 2007;51(5):551-66. doi: 10.1111/j.1348-0421.2007.tb03933.x. Microbiol Immunol. 2007. PMID: 17579266 Free article.

7

Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts.

Muso E, Endo T, Itabashi M, Kakita H, Iwasaki Y, Tateishi Y, Komiya T, Ihara T, Yumura W, Sugiyama T, Joh K, Suzuki K. Muso E, et al. Clin Exp Nephrol. 2013 Oct;17(5):659-662. doi: 10.1007/s10157-012-0755-7. Epub 2012 Dec 21. Clin Exp Nephrol. 2013. PMID: 23263238 Free PMC article.

8

Correlation between the severity of clinicopathological parameters and whole blood interferon-alpha production capacity in active phase IgA nephropathy patients.

Shirakawa K, Muso E, Nogaki F, Maeda M, Kawamura T, Ono T, Yoshimoto M, Uno K, Kishida T, Sasayama S. Shirakawa K, et al. Among authors: muso e. Nephron. 2002 Jan;90(1):24-30. doi: 10.1159/000046310. Nephron. 2002. PMID: 11744801

9

Neutrophil contribution to the crescentic glomerulonephritis in SCG/Kj mice.

Ishida-Okawara A, Ito-Ihara T, Muso E, Ono T, Saiga K, Nemoto K, Suzuki K. Ishida-Okawara A, et al. Among authors: muso e. Nephrol Dial Transplant. 2004 Jul;19(7):1708-15. doi: 10.1093/ndt/gfh275. Epub 2004 May 18. Nephrol Dial Transplant. 2004. PMID: 15150352

10

Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen.

Yamanishi Y, Ito-Ihara T, Nagao T, Uno K, Kobayashi S, Muso E, Shane PY, Firestein GS, Hashimoto H, Okazaki T, Suzuki K. Yamanishi Y, et al. Among authors: muso e. Mod Rheumatol. 2013 Sep;23(5):963-71. doi: 10.1007/s10165-012-0781-z. Epub 2012 Oct 21. Mod Rheumatol. 2013. PMID: 23085883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters